Arvind Kush insider trades: Inhibikase Therapeutics (IKT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Arvind reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 21, 2024 | IKT | ↑ Buy | 145,000 | $1.37 | $199K | Direct | Oct 23, 2024 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other IKT insiders
Open-market trades in the last 12 months
About Arvind Kush's insider trades
Arvind Kush is an insider at Inhibikase Therapeutics (IKT). Since Oct 21, 2024, Arvind has reported 1 open-market purchase worth $199K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (4 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every IKT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.